HomeInsideCaplin Point Labs gets USFDA approval for its new anticholinergic drug

Caplin Point Labs gets USFDA approval for its new anticholinergic drug

Reader's Pick

India based mid-cap pharmaceutical company. Caplin Point Laboratories has announced that “One of its subsidiaries received an anticholinergic drug approval from US health regulator.”

The company in its statement on Friday said that “Caplin Steriles a wholly owned subsidiary of Caplin Point Laboratories has been granted final approval by the United States Food and Drug Administration (USFDA) for its abbreviated new drug for the application (ANDA) Glycopyrrolate injection USP 0.mg/ml.”

The company’s chairman, C C Paarthipan in his statement said that “It is an important milestone in our journey in the regulated markets and we’re working towards launching the product shortly in the US market.”

Glycopyrrolate is a generic therapeutic equivalent version of Robinul from West-Ward Pharmaceuticals International Limited.

- Advertisement -

According to IQVIA (IMS Health), Glycopyrrolate had a US sales data of approximately $110.12 Million for the 12 months ending December 2018.

Caplin Sterlies has so far developed and filed 11 ANDAs in which seven are of Caplin Steriles and 4 with the partners. The company has so now got four approvals in which three approvals are through partners, and current approval is the first under its name.


Stay on top of Budget 2023 with our newsletter

We don’t spam! Read our privacy policy for more info.


Stay on top of Budget 2023 with our newsletter

We don’t spam! Read our privacy policy for more info.

- Advertisement -

Read latest Business News and Startup news on TechGraph. Watch live and latest news on TechGraph TV. Follow us on Facebook or follow us on Twitter and Instagram. Listen audio news from TechGraph Briefings on Spotify, Google Podcast, Amazon Music & on Apple Podcast.

Krishna Mali
Krishna Mali
Founder & Editor of TechGraph.

Latest News

Promoted Links

Related Stories

Japan approves 26 trillion yen as economic stimulus package to combat overseas risks

Japan's cabinet approved an economic stimulus package worth 26 trillion yen ($2...

Sino-US trade war offers Europe’s chance to bank more Chinese reserves: Analysis

Should European countries want the euro to replace the dollar as the world's do...

1Win App: Review India Apk for Android and iOS

The company 1Win has been successfully operating in the markets of many countri...

Employees union seeks FIR against Jet Airways boss Naresh Goyal, Vinay Dube and on SBI Chairman

The employee union of Jet Airways, which is facing its worst crisis, Friday sou...

Samsung Electronics asks its shareholders to use electronic voting for upcoming AGM

Technology giant Samsung Electronics has adopted electronic voting for the firs...

Rahul Gandhi hits on RCEP says, ‘Make in India’ has become ‘Buy from China’

Asserting that "Make in India" has become "Buy from China," Congress leader Rah...

NASA astronauts to carry first ever all-female spacewalk on 29 March

Two NASA astronauts are scheduled to carry out the first ever all-female spacew...

Union Budget 2023: Five Major Changes to the Personal Income Tax Regime

In a major announcement on income tax changes, the government has revealed five...

Union Budget 2023: Infrastructure Investment with Steep Capital Outlay

The Finance Minister, Nirmala Sitharaman, has announced the Union Budget 2023 w...

What Jammu & Kashmir, Ladakh, Northeast & Agritech got from Budget 2023?

Addressing the parliament on the ongoing union budget session, Finance Minister...